AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Industry executive named to vaccine developer's board.
2002 NOV 20 - (NewsRx.com & NewsRx.net) -- ID Biomedical announced the appointment of Michel Greco to its board of directors.
Greco has had a long career in the pharmaceutical and vaccine industry. In 1998, he was appointed president and COO, then deputy CEO of Aventis Pasteur, a prominent vaccine manufacturer. He currently is a supervisory board member of Aventis Pasteur.
From 1994 to 1998, Greco was president and chief executive officer of Pasteur Merieux MSD, a European joint venture between Aventis Pasteur and Merck and Co. He has also held a number of industry-wide responsibilities over the years, including president of the European Vaccine Manufacturers Group, chairman of the Biological Committee of the International Federation of Pharmaceutical Manufacturers Associations, as well as a member of the World Health Organization (WHO) Vaccines and Biologicals' ...
- Aventis Pasteur Announces Plans to Meet U.S. Demand for Influenza Vaccine.
- Press release article from: PR Newswire December 2, 2002 700+ words
SWIFTWATER, Pa. -- Aventis Pasteur, the nation's largest supplier...production of its influenza vaccine. Aventis Pasteur's Swiftwater, PA, facility...vaccine used in the U.S. Aventis Pasteur globally produces more than...
- Aventis Pasteur Produces 50 Million Doses of Influenza Vaccine, Distributes 49...
- Press release article from: PR Newswire December 3, 2001 700+ words
SWIFTWATER, Pa. -- Aventis Pasteur today announced the company...million doses of vaccine. "Aventis Pasteur has produced an unprecedented...president, marketing and sales, Aventis Pasteur. "The company achieved these...
- Aventis Pasteur Acquires Exclusive Rights to Develop Novel Cancer Targets...
- Press release article from: PR Newswire January 13, 2003 700+ words
...PRNewswire/ -- Eos Biotechnology and Aventis Pasteur today announced that a two-year...cancer vaccine targets has resulted in Aventis Pasteur exercising its options to develop...targets. Under terms of the agreement, Aventis Pasteur is granted the exclusive worldwide...
- Aventis Pasteur Donates Cell Line to the U.S. for SARS Vaccine Research; Goal...
- Press release article from: Business Wire April 10, 2003 700+ words
...BUSINESS WIRE)--April 10, 2003 Aventis Pasteur announced today that it will transfer...Acute Respiratory Syndrome, or SARS. Aventis Pasteur was contacted by government officials...chairman, president and CEO of Aventis Pasteur, the vaccines unit of Aventis...
- Aventis Pasteur Announces Closing of Virogenetics Facility.
- Press release article from: PR Newswire June 22, 2000 700+ words
...Pa., June 22 /PRNewswire/ -- Aventis Pasteur announced today that the Virogenetics...morning by the Board of Directors. Aventis Pasteur first became affiliated with Virogenetics...are currently in clinical trials. Aventis Pasteur intends to continue development of...
- Aventis Pasteur and FibroGen Sign Strategic Vaccine Agreement; Aventis Pasteur...
- Press release article from: Business Wire January 18, 2001 700+ words
...BW HealthWire)--Jan. 18, 2001 Aventis Pasteur, SA (NYSE:AVE) and the FibroGen...activity attenuation specific for certain Aventis Pasteur vaccines. The collaboration will...development work focusing on selected Aventis Pasteur vaccines and potential for additional...
- More Than Two-Thirds of Aventis Pasteur's Influenza Vaccine Shipped by October...
- Press release article from: PR Newswire November 9, 2001 700+ words
...Pa., Nov. 9 /PRNewswire/ -- Aventis Pasteur, the nation's leading supplier...allocated to customers currently on Aventis Pasteur's waiting list, with priority given...the additional five million doses, Aventis Pasteur will have produced a total of 50 million...
- More Than Two-thirds of Aventis Pasteur's Influenza Vaccine Shipped by October...
- Press release article from: Business Wire November 9, 2001 700+ words
...Extra Doses to Ship in Late-November Aventis Pasteur, the nation's leading supplier...allocated to customers currently on Aventis Pasteur's waiting list, with priority given...the additional five million doses, Aventis Pasteur will have produced a total of 50 million...
- Aventis Pasteur to Complete Partial Shipments of Influenza Vaccine to All...
- Press release article from: Business Wire September 25, 2001 700+ words
...Receive Balance in October/November Aventis Pasteur, the nation's leading supplier...November. "We are pleased that all Aventis Pasteur customers will receive influenza vaccine...president, marketing and sales at Aventis Pasteur. The company's smaller customers...
- Aventis Pasteur to Begin Shipping Preservative-Free Influenza Vaccine for...
- Press release article from: PR Newswire November 4, 2002 700+ words
SWIFTWATER, Pa. -- Aventis Pasteur today announced that the company...children aged six to 35 months. "Aventis Pasteur is pleased to be able to provide...products and immunization policy at Aventis Pasteur. "This is a clear demonstration...
Source: HighBeam Research, Industry executive named to vaccine developer's board.